{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:15:22Z","timestamp":1791976522753,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11154-020-09605-1","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T04:32:04Z","timestamp":1602045124000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Individual sensitivity to growth hormone replacement in adults"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-7941","authenticated-orcid":false,"given":"Cesar Luiz","family":"Boguszewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"issue":"6","key":"9605_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.20945\/2359-3997000000183","volume":"63","author":"CL Boguszewski","year":"2019","unstructured":"Boguszewski CL, Boguszewski MCDS. What\u2019s in a name? What we call growth hormone is much more than just a growth-related peptide. Arch Endocrinol Metab. 2019;63(6):546\u20138.","journal-title":"Arch Endocrinol Metab"},{"issue":"Suppl 1","key":"9605_CR2","first-page":"2","volume":"16","author":"M Buchman","year":"2018","unstructured":"Buchman M, Bell S, Kopchick JJ. Growth hormone discovery and structure. Pediatr Endocrinol Rev. 2018;16(Suppl 1):2\u201310.","journal-title":"Pediatr Endocrinol Rev"},{"key":"9605_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-3-540-79088-4_8","volume":"195","author":"M Bidlingmaier","year":"2010","unstructured":"Bidlingmaier M, Strasburger CJ. Growth hormone. Handb Exp Pharmacol. 2010;195:187\u2013200.","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"9605_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41467-019-08607-1","volume":"10","author":"IC Furigo","year":"2019","unstructured":"Furigo IC, Teixeira PDS, de Souza GO, Couto GCL, Romero GG, Perell\u00f3 M, Fraz\u00e3o R, Elias LL, Metzger M, List EO, Kopchick JJ, Donato J Jr. Growth hormone regulates neuroendocrine responses to weight loss via AgRP neurons. Nat Commun. 2019;10(1):662.","journal-title":"Nat Commun"},{"key":"9605_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000452913","volume":"48","author":"G Bodart","year":"2017","unstructured":"Bodart G, Farhat K, Charlet-Renard C, Salvatori R, Geenen V, Martens H. The somatotrope growth hormone-releasing hormone\/growth hormone\/insulin-like growth factor-1 axis in immunoregulation and immunosenescence. Front Horm Res. 2017;48:147\u201359.","journal-title":"Front Horm Res"},{"issue":"5","key":"9605_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2265.1992.tb02347.x","volume":"37","author":"RC Cuneo","year":"1992","unstructured":"Cuneo RC, Salomon F, McGauley GA, S\u00f6nksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf). 1992;37(5):387\u201397.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9605_CR7","doi-asserted-by":"crossref","unstructured":"Boguszewski CL. Update on GH therapy in adults. F1000Res. 2017;6:2017.","DOI":"10.12688\/f1000research.12057.1"},{"issue":"4","key":"9605_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/cen.13147","volume":"85","author":"V Chikani","year":"2016","unstructured":"Chikani V, Cuneo RC, Hickman I, Ho KK. Growth hormone (GH) enhances anaerobic capacity: impact on physical function and quality of life in adults with GH deficiency. Clin Endocrinol (Oxf). 2016;85(4):660\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8649","key":"9605_CR9","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","volume":"1","author":"JO J\u00f8rgensen","year":"1989","unstructured":"J\u00f8rgensen JO, Pedersen SA, Thuesen L, J\u00f8rgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1989;1(8649):1221\u20135.","journal-title":"Lancet"},{"issue":"26","key":"9605_CR10","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","volume":"321","author":"F Salomon","year":"1989","unstructured":"Salomon F, Cuneo RC, Hesp R, S\u00f6nksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989;321(26):1797\u2013803.","journal-title":"N Engl J Med"},{"issue":"2","key":"9605_CR11","first-page":"379","volume":"83","author":"No authors listed","year":"1998","unstructured":"No authors listed. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab. 1998;83(2):379\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"9605_CR12","doi-asserted-by":"crossref","unstructured":"Ho KK. 2007 GH Deficiency Consensus Workshop Participants. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007;157(6):695\u2013700.","DOI":"10.1530\/EJE-07-0631"},{"issue":"6","key":"9605_CR13","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. J Clin Endocrinol Metab. 2011;96(6):1587\u2013609.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"9605_CR14","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4158\/GL-2019-0405","volume":"25","author":"KCJ Yuen","year":"2019","unstructured":"Yuen KCJ, Biller BMK, Radovick S, Carmichael JD, Jasim S, Pantalone KM, Hoffman AR. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care. Endocr Pract. 2019;25(11):1191\u2013232.","journal-title":"Endocr Pract"},{"issue":"9","key":"9605_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1590\/S0004-27302013000900006","volume":"57","author":"CL Boguszewski","year":"2013","unstructured":"Boguszewski CL, Lacerda CS, Lacerda Filho L, Carvalho JA, Boguszewski MC. Reappraisal of serum insulin-like growth factor-I (IGF-1) measurement in the detection of isolated and combined growth hormone deficiency (GHD) during the transition period. Arq Bras Endocrinol Metabol. 2013;57(9):709\u201316.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"9605_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.beem.2017.02.001","volume":"31","author":"F Tanriverdi","year":"2017","unstructured":"Tanriverdi F, Kelestimur F. Classical and non-classical causes of GH deficiency in adults. Best Pract Res Clin Endocrinol Metab. 2017;31(1):3\u201311.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"9605_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.ghir.2007.04.010","volume":"17","author":"P Clayton","year":"2007","unstructured":"Clayton P, Gleeson H, Monson J, Popovic V, Shalet SM, Christiansen JS. Growth hormone replacement throughout life: insights into age-related responses to treatment. Growth Horm IGF Res. 2007;17(5):369\u201382.","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"9605_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1210\/jc.2003-030685","volume":"89","author":"RD Murray","year":"2004","unstructured":"Murray RD, Columb B, Adams JE, Shalet SM. Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly. J Clin Endocrinol Metab. 2004;89(3):1124\u201330.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"9605_CR19","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1210\/jcem.86.10.7896","volume":"86","author":"J Koranyi","year":"2001","unstructured":"Koranyi J, Svensson J, G\u00f6therstr\u00f6m G, Sunnerhagen KS, Bengtsson B, Johannsson G. Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. J Clin Endocrinol Metab. 2001;86(10):4693\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9605_CR20","first-page":"82","volume":"82","author":"AF Attanasio","year":"1997","unstructured":"Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BA, Strasburger CJ. Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab. 1997;82(1):82\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9605_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1530\/EJE-07-0016","volume":"156","author":"H Urushihara","year":"2007","unstructured":"Urushihara H, Fukuhara S, Tai S, Morita S, Chihara K. Heterogeneity in responsiveness of perceived quality of life to body composition changes between adult- and childhood-onset Japanese hypopituitary adults with GH deficiency during GH replacement. Eur J Endocrinol. 2007;156(6):637\u201345.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9605_CR22","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1210\/jcem.84.1.5408","volume":"84","author":"AA Toogood","year":"1999","unstructured":"Toogood AA, Shalet SM. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study. J Clin Endocrinol Metab. 1999;84(1):131\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9605_CR23","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/EJE-18-0306","volume":"179","author":"JOL J\u00f8rgensen","year":"2018","unstructured":"J\u00f8rgensen JOL, Juul A. THERAPY OF ENDOCRINE, DISEASE. Growth hormone replacement therapy in adults: 30 years of personal clinical experience. Eur J Endocrinol. 2018;179(1):R47\u201356.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9605_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.beem.2017.03.003","volume":"31","author":"V Birzniece","year":"2017","unstructured":"Birzniece V, Ho KKY. Sex steroids and the GH axis: Implications for the management of hypopituitarism. Best Pract Res Clin Endocrinol Metab. 2017;31(1):59\u201369.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"9605_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ghir.2019.09.002","volume":"50","author":"MM Weber","year":"2020","unstructured":"Weber MM, Gordon MB, H\u00f6ybye C, J\u00f8rgensen JOL, Puras G, Popovic-Brkic V, Molitch ME, Ostrow V, Holot N, Pietropoli A, Biller BMK. Growth hormone replacement in adults: Real-world data from two large studies in US and Europe. Growth Horm IGF Res. 2020;50:71\u201382.","journal-title":"Growth Horm IGF Res"},{"issue":"2","key":"9605_CR26","first-page":"550","volume":"82","author":"P Burman","year":"1997","unstructured":"Burman P, Johansson AG, Siegbahn A, Vessby B, Karlsson FA. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab. 1997;82(2):550\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9605_CR27","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ghir.2008.07.001","volume":"19","author":"C Franco","year":"2009","unstructured":"Franco C, Koranyi J, Brandberg J, L\u00f6nn L, Bengtsson BK, Svensson J, Johannsson G. The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women. Growth Horm IGF Res. 2009;19(2):112\u201320.","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"9605_CR28","first-page":"1575","volume":"81","author":"G Johannsson","year":"1996","unstructured":"Johannsson G, Bjarnason R, Bramnert M, Carlsson LM, Degerblad M, Manhem P, Ro\u015ben T, Thor\u00e9n M, Bengtsson BA. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J Clin Endocrinol Metab. 1996;81(4):1575\u201381.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"9605_CR29","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1210\/jc.2003-032082","volume":"89","author":"AR Hoffman","year":"2004","unstructured":"Hoffman AR, Strasburger CJ, Zagar A, Blum WF, Kehely A, Hartman ML, T002 Study Group. Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing. J Clin Endocrinol Metab. 2004;89(7):3224\u201333.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"9605_CR30","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1530\/EJE-13-0005","volume":"168","author":"U Feldt-Rasmussen","year":"2013","unstructured":"Feldt-Rasmussen U, Brabant G, Maiter D, Jonsson B, Toogood A, Koltowska-Haggstrom M, Rasmussen AK, Buchfelder M, Saller B, Biller BM. Response to GH treatment in adult GH deficiency is predicted by gender, age, and IGF1 SDS but not by stimulated GH-peak. Eur J Endocrinol. 2013;168(5):733\u201343.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"9605_CR31","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1365-2265.2000.00971.x","volume":"52","author":"RD Murray","year":"2000","unstructured":"Murray RD, Howell SJ, Lissett CA, Shalet SM. Pre-treatment IGF-I level is the major determinant of GH dosage in adult GH deficiency. Clin Endocrinol (Oxf). 2000;52(5):537\u201342.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"9605_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1530\/EJE-09-0973","volume":"162","author":"EJ Barbosa","year":"2010","unstructured":"Barbosa EJ, Koranyi J, Filipsson H, Bengtsson BA, Boguszewski CL, Johannsson G. Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults. Eur J Endocrinol. 2010;162(5):869\u201378.","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"9605_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta6190","volume":"6","author":"J Bryant","year":"2002","unstructured":"Bryant J, Loveman E, Chase D, Mihaylova B, Cave C, Gerard K, Milne R. Clinical effectiveness and cost-effectiveness of growth hormone in adults in relation to impact on quality of life: a systematic review and economic evaluation. Health Technol Assess. 2002;6(19):1\u2013106.","journal-title":"Health Technol Assess"},{"key":"9605_CR34","unstructured":"National Institute for Clinical Excellence (NICE). Human growth hormone (somatropin) in adults with growth hormone deficiency. 36 NICE, London. 2003. Available at: http:\/\/guidance.nice.org.uk\/TA64. Accessed 16 Apr 2020."},{"issue":"4","key":"9605_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1023\/A:1008987922774","volume":"8","author":"SP McKenna","year":"1999","unstructured":"McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, W\u00edren L. The QoL-AGHDA: an instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res. 1999;8(4):373\u201383.","journal-title":"Qual Life Res"},{"issue":"2","key":"9605_CR36","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/EJE-16-1047","volume":"177","author":"MH Aguiar-Oliveira","year":"2017","unstructured":"Aguiar-Oliveira MH, Souza AHO, Oliveira CRP, Campos VC, Oliveira-Neto LA, Salvatori R. The multiple facets of GHRH\/GH\/IGF-I axis: lessons from lifetime, untreated, isolated GH deficiency due to a GHRH receptor gene mutation. Eur J Endocrinol. 2017;177(2):R85\u201397.","journal-title":"Eur J Endocrinol"},{"key":"9605_CR37","unstructured":"Snyder PJ. Growth hormone deficiency in adults. In: UpToDate Post TW, editor, UpToDate, Waltham, MA. Accessed 5 May\u00a02020."},{"issue":"3","key":"9605_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1530\/EJE-12-0263","volume":"167","author":"EJ Barbosa","year":"2012","unstructured":"Barbosa EJ, Glad CA, Nilsson AG, Filipsson Nystr\u00f6m H, G\u00f6therstr\u00f6m G, Svensson PA, Vinotti I, Bengtsson BA, Nilsson S, Boguszewski CL, Johannsson G. Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy. Eur J Endocrinol. 2012;167(3):353\u201362.","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"9605_CR39","doi-asserted-by":"publisher","first-page":"e105754","DOI":"10.1371\/journal.pone.0105754","volume":"9","author":"EJ Barbosa","year":"2014","unstructured":"Barbosa EJ, Glad CA, Nilsson AG, Bosaeus N, Nystr\u00f6m HF, Svensson PA, Bengtsson BA, Nilsson S, Bosaeus I, Boguszewski CL, Johannsson G. Extracellular water and blood pressure in adults with growth hormone (GH) deficiency: a genotype-phenotype association study. PLoS One. 2014;9(8):e105754.","journal-title":"PLoS One"},{"issue":"1","key":"9605_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-13-0685","volume":"170","author":"CA Glad","year":"2013","unstructured":"Glad CA, Barbosa EJ, Filipsson Nystr\u00f6m H, Carlsson LM, Nilsson S, Nilsson AG, Svensson PA, Johannsson G. SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults. Eur J Endocrinol. 2013;170(1):101\u20137.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9605_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1210\/jc.2008-0323","volume":"94","author":"EJ Barbosa","year":"2009","unstructured":"Barbosa EJ, Palming J, Glad CA, Filipsson H, Koranyi J, Bengtsson BA, Carlsson LM, Boguszewski CL, Johannsson G. Influence of the exon 3-deleted\/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency. J Clin Endocrinol Metab. 2009;94(2):639\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9605_CR42","doi-asserted-by":"publisher","first-page":"R309","DOI":"10.1530\/EJE-17-0549","volume":"177","author":"CL Boguszewski","year":"2017","unstructured":"Boguszewski CL, Barbosa EJL, Svensson PA, Johannsson G, Glad CAM. Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism. Eur J Endocrinol. 2017;177(6):R309\u201321.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"9605_CR43","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/cen.13030","volume":"84","author":"MK Auer","year":"2016","unstructured":"Auer MK, Stieg MR, Hoffmann J, Stalla GK. Is insulin-like growth factor-I a good marker for treatment adherence in growth hormone deficiency in adulthood? Clin Endocrinol (Oxf). 2016;84(6):862\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"9605_CR44","doi-asserted-by":"publisher","first-page":"143","DOI":"10.4158\/EP.14.2.143","volume":"14","author":"RG Rosenfeld","year":"2008","unstructured":"Rosenfeld RG, Bakker B. Compliance and persistence in pediatric and adult patients receiving growth hormone therapy. Endocr Pract. 2008;14(2):143\u201354.","journal-title":"Endocr Pract"},{"issue":"5","key":"9605_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1586\/17434440.2015.1069180","volume":"12","author":"AM Kappelgaard","year":"2015","unstructured":"Kappelgaard AM, Metzinger CP, Schnabel D. A web-based survey assessing the impact of storage flexibility on the daily life of patients and caregivers administering growth hormone. Expert Rev Med Devices. 2015;12(5):517\u201327.","journal-title":"Expert Rev Med Devices"},{"issue":"6","key":"9605_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.20945\/2359-3997000000190","volume":"63","author":"RA Lal","year":"2019","unstructured":"Lal RA, Hoffman AR. Perspectives on long-acting growth hormone therapy in children and adults. Arch Endocrinol Metab. 2019;63(6):601\u20137.","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"9605_CR47","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000351025","volume":"79","author":"JM Wit","year":"2013","unstructured":"Wit JM, Ranke MB, Albertsson-Wikland K, Carrascosa A, Rosenfeld RG, Van Buuren S, Kristrom B, Schoenau E, Audi L, Hokken-Koelega AC, Bang P, Jung H, Blum WF, Silverman LA, Cohen P, Cianfarani S, Deal C, Clayton PE, de Graaff L, Dahlgren J, Kleintjens J, Roelants M. Personalized approach to growth hormone treatment: clinical use of growth prediction models. Horm Res Paediatr. 2013;79(5):257\u201370.","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"9605_CR48","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1530\/EJE-15-0305","volume":"173","author":"HJ Schneider","year":"2015","unstructured":"Schneider HJ, Buchfelder M, Wallaschofski H, Luger A, Johannsson G, Kann PH, Mattsson A. Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency. Eur J Endocrinol. 2015;173(6):843\u201351.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"9605_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12902-018-0237-3","volume":"18","author":"PH Kann","year":"2018","unstructured":"Kann PH, Bergmann S, Bidlingmaier M, Dimopoulou C, Pedersen BT, Stalla GK, Weber MM, Meckes-Ferber S. Design of the growth hormone deficiency and Efficacy of Treatment (GET) score and non-interventional proof of concept study. BMC Endocr Disord. 2018;18(1):10.","journal-title":"BMC Endocr Disord"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-020-09605-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-020-09605-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T23:29:06Z","timestamp":1633562946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-020-09605-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["9605"],"URL":"https:\/\/doi.org\/10.1007\/s11154-020-09605-1","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"assertion":[{"value":"2 October 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author has no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}